The SMN2 gene is a classic model of exon skipping caused by a synonymous nucleotide variant in an exonic regulatory sequence, and its modulation forms the basis for several therapeutic strategies under development for SMA, as mentioned above3. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.